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Abstract
BACKGROUND: Multifunctional nanoparticles are known for their wide range of biomedical applications. Controlling the 
magnetic properties of these nanoparticles is imperative for various applications, including therapeutic angiogenesis. 
AIM:  The study was performed to evaluate the magnetic properties and their control mechanisms by the external 
magnetic field.
METHODS: A 100 nm magnetic nanoparticle was placed in the magnetic field, and parametrically, the magnet field 
strength and distance were evaluated. Various models of magnetic strength and disposition were evaluated. Magnetic 
flux density, force/weight, and magnetic gradient strength were the parameters evaluated in the electromagnetic 
computational software.
RESULTS: The seven-coil method with three centrally placed coils as Halbach array, and each coil with a flux density 
of 7 Tesla, and with a coil dimension of 20 cm × 20 cm (square model) of each coil showed a good magnetic strength 
and force/weight parameters in a distance of 15 cm from the centrally placed coil. The particles were then evaluated 
for their motion characteristics in saline. It showed good displacement and acceleration properties. After that, the 
particles were theoretically assessed in a similar mathematical model after parametrically correcting the drag force. 
After the application of high drag forces, the particles showed adequate motion characteristics. When the particle 
size was reduced further, the motion characteristics were preserved even with high drag forces.
CONCLUSION: There is potential for a novel method of controlling multifunctional magnetic nanoparticles using high 
magnetic fields. Further studies are required to evaluate the motion characteristics of these particles in vivo and in vitro.
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Introduction
Magnetic nanoparticles are multifunctional 
and they are also carriers of various biomolecules. 
They are currently used for various biomedical 
applications  [1], [2], [3]. The particle has unique properties 
after surface modification and conjugation with various 
biomolecules [4], [5], [6], [7], [8]. Their physical and certain 
biochemical properties can be magnetically controlled [8]. 
In the previous studies to a very limited extent, the motion 
of the particles was studied and the magnetic field 
strength used was minimal. The purpose of this study was 
to evaluate the magnetic properties of these magnetic 
nanoparticles in large magnetic field strength and to 
identify its magnetic and motion dynamics in saline and 
tissues. The details of the magnetic properties of these 
magnetic nanoparticles in large magnetic field are 
currently not available. The study was performed with 
the focus of cardiovascular applications, and the results 
could also be extrapolated to a wide range of applications, 
for example, neurovascular and renal diseases. The 
magnetic nanoparticles have shown the potentials of 
angiogenesis in the previous study [9]. Hence, steering 
the magnetic nanoparticles in the required areas could 
result in angiogenesis, which could evolve as a potential 
novel therapy. The results would be useful for a wide 
range of applications in the biomedical fields.
Methods
Their interaction in high magnetic field needs 
to be studied in detail. Magnetic field and intensity 
follow the basic principles of magnetism, i.e., Maxwell’s 
and Faraday’s equations [10], [11]. In this study, we 
performed an electromagnetic simulation of magnetic 
field with high magnetic intensity by parametric variations 
in intensity position and magnetic nanoparticle sizes. 
The trend in magnetic field intensity and magnetic 
field force predominantly in X-axis and in some Y-axis 
force parameters was computed. The magnetic field 
strength of each magnetic coil was increased to 7T. 
Furthermore, to increase the magnetic strength, further 
the coil dimensions were varied and then the Halbach 
array technique to amplify magnetic intensity was 
used [12], [13]. The position and the number of coils 
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Figure 2a shows the placement of the 5T 
magnets in the +135 and +225, and the polarity of 
the magnets is the same as that of the magnet placed 
in the opposite site (0 degree). The zero in Table 2b 
indicates the surface of the 5T magnet at zero degrees. 
A high force/weight of about 12 was generated, but it 
falls acutely after 2cm distance from the magnet. The 
polarity of the magnets at +135 and -225 degrees 
was reversed, and the magnet at zero degrees had 
were increased and the angulations were modified and 
thereafter the results were studied. The standard particle 
size of 100 nm was assumed in most experiments. The 
particle dimensions were reduced later parametrically 
and their magnetic properties were studied.
The force/weight acting on the particle in the 
various models was also estimated. A 100 nm magnetic 
nanoparticle was placed in the magnetic field and using 
finite element analysis, the electromagnetic behavior of 
the particle was studied in Quickfield software, and the 
results were computed two-dimensionally, for evaluation, 
single coils were used. The coil strength was increased 
by increasing the number of turns in the coils. When 
the force acting on the particles was evaluated, the 
displacement and acceleration kinetics of the particles 
were studied in saline and to model the tissues, the drag 
forces were increased up to 1000 times to simulate the 
motion in tissues with higher values. In the initial part of the 
study, nickel (Ni) rings were placed at various locations 
from the electromagnets and maximum electric current 
(A/C or D/C) was passed in these Ni rings. This is to 
study the electromagnetic distortions and eddy currents 
which tend to form by the Ni rings when placed near 
high magnetic fields. The details of the model and the 
elaborate results are available in the Quickfield website. 
The supplement website gives elaborate details of the 
calculations including force, the force/weight values, 
and motion dynamics of the nanoparticles.
Supplement website file http://quickfield.com/
publications/MarkArokiaraj
Initially, a single coil was placed (Figure 1a) 
and the magnetic flux density and gradient in X-axis 
were measured by the Quickfield electromagnetic 
software (Figure 1b). Thereafter, the coils were added, 
and they had a flux density of 5T at different locations at 
the point of interest. The flux density and force/weight 
were measured in X-axis (supplement file 3).
Figure 2a and b: Three 5T coils location (+135 and +225°). Force 
parameters are given in the supplement file 11 (Excel file)
a
b
Figure 1a and b: Single coil evaluation in 5T magnetic flux density
b
a
Figure 3a and b: Three 5T coils location (+135 and −225°). Force 
parameters are given in the supplement file 1 (Excel file 1)
a
b
the same polarity, as shown in Figure 3a. The force 
parameters (Figure3b) were almost the same as the 
Figure 2 arrangement. Next, the 5T magnets with the 
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same polarity were placed side by side (Figure 4a), and 
the force parameters showed a high negative force of 
about 2T (violet areas) in between the 5T magnets.  In 
this arrangement also, the magnetic flux density falls 
in 2 to 3 cm away from the magnetic field (Figure 4b). 
Figure 7a: Five-coil technique with double distance, i.e. the point of 
interest is located 30 cm from the central coil
Figure 7b: Five-coil technique with double distance, i.e. the point of 
interest is located 30 cm from the central coil
Figure 4a and b: Three 5T coils location (+45 and +315°). Force 
parameters are given in the supplement file 1 (Excel file 1)
a
b
Figure 5a and b: Three 5T coils location (−45 and −315°). Force 
parameters are given in the supplement file 11 (Excel file)
a
b
Figure 6a and b: Five-coil simulation force parameters (3 × 5T outer 
coils and 2 × 2T inner coils located near the point of interest located 
10 cm from the central coils)
a
b
In the next arrangement (Figure 5a) the polarity of the 
magnets was reversed in the outer magnets. The force 
parameters showed a fall of the force parameters at 
2.5cm to 2T (Figure 5b). In the next arrangement 3 
outer 5T coils were placed and 2 coils of 2T was placed 
internally as shown in Figure 6a. The force/weight was 
high near the magnet and rapidly falls and again at 
5–7 cm from the coils, and a spike of increased force/
weight was observed (Figure 6b). The force parameters 
are given in supplement le attached 5-coil simulation 
with 30 cm distance. The analysis in the violet areas 
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in Figure 6a is given in supplement file as – violet area 
evaluation. 
The 5T magnets were moved apart, and the point 
of interest was placed 30cm from the magnetic surface of 
the magnet set in the x-axis (Figure 7a). The force generated 
was not appreciable, and it was not significantly different 
from the closely place magnets (Figure 7b). However, in 
between the large magnets, a light blue zone of about 0.8 
T was seen (Figure 7b). In the next arrangement the coils 
were again closely placed, and the point of interest was 
away from 10cm from the surface of the x-axis magnet 
(Figure 8a). Ni rings were placed away from the point of 
interest, and A/C was used in the Ni. However, the magnetic 
parameters were not significantly different (Figure 8b).  In 
the next arrangement the Halbach array was removed 
and the 7 magnets with 7T coils were placed serially in 
C-manner (Figure 9a) and the force parameters were 
present only near the central magnet. This also emphasizes 
the importance of Halbach array’s contribution to extent the 
magnetic forces away from the central magnet. 
Figure 10a shows the arrangement of coils 
(seven 7T magnets) with three central coils in the 
Halbach arrangement. The x-axis magnetic flux density 
generated after the simulation is shown in Figure 10b, 
and Figure 10c illustrates the extent of distribution of 
the flux density from the surface of the central magnet 
to point 0 located 30cm away from the surface of the 
central magnet. 
Figure 8a: Simulation with five coils with two Ni rings with A/C current. 
Force parameters are given in supplement file 2
Figure 8b: Simulation with five coils with two Ni rings with A/C current. 
Force parameters are given in supplement file 2
Figure 9a: 7 × 7T coils setup and the point of interest in X-plane
Figure 9b: 7 × 7T coils setup and the point of interest in X-plane
Figure 11 shows the magnetic flux density 
parameters in a similar seven coil model with three central 
Halbach. The force parameters in x-axis are given in 
supplement 28. The force/weight parameters were higher 
around the magnet, and it extends about 15cm on either 
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Figure 9c: Results of 7-coil setup with charts showing X and Y forces
Figure 10a: Seven coils with three coils at central Halbach location – 
each coil dimension 15 × 15 cm and its flux density. Force parameters 
are given in supplement file 2
Figure 10b: Seven coils with three coils at central Halbach location – 
each coil dimension 15 × 15 cm and its flux density. Force parameters 
are given in supplement file 27
Figure 10c: Seven coils with three coils at central Halbach location – 
each coil dimension 15 × 15 cm
Figure 11: Seven coils with three coils at central Halbach location 
– each coil dimension 20 × 20 cm. Force parameters are given in 
supplement 28 (particle size 100 nm)
Figure 12a: Ellipsoidal model with seven coils with three central 
Halbach arrangement (and supplement file 29)
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Figure 12b: Ellipsoidal model with seven coils with three central Halbach 
arrangement. Force parameters are given in supplement file 29
Figure 13a: Model with seven coils without central Halbach 
arrangement
Figure 13b: Back-to-back model with seven coils without three 
central Halbach arrangement. Force parameters in X-axis are given 
in supplement file 30
Figure 13c: Results of the back-to-back model with polarity reversed
Figure 14: The off-axis (G-model) arrangement of coils and the 
results – the force/weight values at different locations are seen in the 
picture (supplement file 35 to 37)
side of the magnet arrangement. After that, the magnet 
surface area was altered to elliptical shape (Figure 12a), 
and the force/ weight parameters and the flux density 
were not significantly different compared to rectangular 
models (Figure 12b and c). The x-axis dimension of the 
ellipsoidal magnets was 15 cm. Subsequently, the study 
A - Basic Sciences Pharmacology
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Figure 15a: Horseshoe model evaluation – maximum power achieved 
due to winding 2.2 T (and supplement file 32 and 33)
Figure 15b: Horseshoe model evaluation – maximum power achieved 
due to winding 2.2 T
Figure 15c: Horseshoe model evaluation – maximum power achieved 
due to winding 2.2 T
Figure 15d: Horseshoe model evaluation – force/weight distribution 
values in X- and Y-axis
Figure 16a: Magnetic nanoparticle motion dynamics in the magnetic 
field (supplement file 41, 42)
Figure 16b: Calculation of the particle motion in the space/air
Figure 16c: Calculation of the particle motion in saline with a drag 
force of 1 (supplement 41)
was performed without the central Halbach arrangement 
(Figure 13a), and the force/weight parameters were 
lesser (Figure 13b and c). Then a randomly arranged 
G model was studied (Figure 14). However, the force/
weight and flux density were not appreciable compared 
to the Halbach arrangement. 
The horse-shoe model (Figure 15a) was used 
to achieve 7T magnetic flux density. However, due 
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Figure 16d: Particle dynamics with the calculation of actual moving 
particle in saline (supplement 42, 43)
Figure 16e: Particle dynamics with the calculation of actual moving 
particle in tissue (3 times more drag force than saline) showing 
definite displacement with magnetic effect (supplement 43)
Figure 16f: Particle dynamics with the calculation of actual moving 
particle in tissue 100 times more drag force than saline) showing 
definite displacement with magnetic effect (supplement file 45)
Figure 16g: Particle dynamics with the calculation of actual moving 
particle in tissue 1000 times more drag force than saline) showing 
definite displacement with magnetic effect. (supplement 45)
to winding in the coils, only a flux density of 2.2 was 
obtained. This is due to the phenomenon of magnetic 
saturation, and to certain extent, this can be improved 
with Neodymium instead of iron core. The particle 
was placed in between the horse-shoe, and the force 
parameters showed dragging the particles on either 
side of the horseshoe limbs, as shown in the figure 15c. 
A magnetic flux density of about 2T extends up to 13cm 
from either side of the horseshoe. (Figure 15b and c). 
The maximal force/weight was 615. 
Figure 17: Particle motion dynamics calculation without inertia and a 
drag force of 1 (supplement 46)
After that, the particle displacement and 
acceleration were studied in air/space without 
resistance or drag force was studied. Figure 16a shows 
the movement of particles, and the velocity of motion 
was about 2cm/s. Figure 16b shows the velocity, 
acceleration, and the magnetic force parameters. 
Figure 16c shows the motion kinetics of the particles with 
a minimal drag force of 1. The particles attain a velocity 
of about 1.9cm/s. Subsequently, the particle dynamics 
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was studied in saline with a density parameter of saline 
fixed as 1127kg/m3. The average velocity of the particle 
was about 2.1cm/s (figure 16d). In the next evaluation 
to mimic tissues, the saline density was used, and in 
that a particle drag force three times the normal was 
simulated Figure 16e. This was primarily to mimic the 
Vander-wall forces and other intermolecular forces in 
the tissue. Figure 16f shows the same parameters at a 
higher drag force of 100 higher than saline. The velocity 
of particle movement was in the range of 0.2cm/s. 
Next, with a tissue drag force of 1000 was used. The 
velocity of particle movement was in the range of 0.02 
to 0.06cm/s (Figure 16g).
Figure 17 shows the simulation of the movement 
of nanoparticles without inertia in saline and a minimal 
force of 1. The particle trajectory can be seen in figure 
1, and the nanoparticle moves towards the magnetic 
arrangement. This proves that the nanoparticles can 
be controlled by the magnetic force appreciably, and 
the particles can move inside the tissues at very high 
magnetic strength. Figure 18 showed the particle 
movement towards the magnetic field when the drag 
force in saline was 1000. The trajectory of the particle 
motion is seen and the velocity is slower. Finally, the 
magnetic size of the nanoparticle was reduced from 
100nm to 15nm, and with the drag force of 1000, the 
particle motion was studied. The velocity attained was 
Figure 18: Particle motion dynamics calculation without inertia and a 
drag force of 1000 and the particle size of 100 nm (supplement 47)
Figure 19: Particle motion dynamics calculation without inertia and 
a drag force of 1000 and the particle size of 15 nm (supplement 48)
Figure 20: Jacobian line matrix assessment for Y-axis force between 
two coils in the violet areas in the following model. Force values of 
the Jacobian line matrix assessment are given in the supplement file 
(Y-axis Jacobian line matrix assessment) (supplement file 24)
lower than the velocity of 100nm particle, which was 
0.02cm/s and in the later, it was about 0.04 to 0.06cm/s 
(Figure 19).
Interestingly in the violet areas of the results 
(Figure 20) interposed between the magnets, the 
force on the 100 nm particle would be 0.19e-12 N. 
This would be approximately 4100 times the particle 
weight. It will be a tremendous joint, and the particle 
will accelerate rapidly, reaching the maximal velocity 
of 0.32 m/s (in saline). Within 50 ms, the particle would 
hit the side of the coil (the distance to the coil is only 
1.5 cm) – the picture attached. The result could be a 
bit unrealistic because in the model we presume that 
magnetic field is instantly switched on (or the particle 
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appears suddenly in the already energized magnetic 
field).
In real life, the particle would travel some 
distance before reaching the zone of high field intensity. 
Or else, in case of switching magnetic field, it will take 
some time to energize the coil fully.
The force/weight parameters on the magnetic 
nanoparticles reflect the magnetic controllability of the 
particles. The dB/dx indicates the magnetic flux density, 
and higher the magnetic flux generated results in more 
force acting on the particles. The higher the distance the 
force/weight parameters and the flux density are observed 
the higher the degree of the distance to which the particles 
are controlled. The various models tested were developed 
by changing the shape, dimensions, and the number of the 
magnetic coils to achieve an optimal magnetic flux density. 
The magnetic flux density achieved in the Y-axis (dB/dy) is 
comparatively lesser figure than dB/dx. However, the flux 
density reached in one axis, i.e. dB/dx, is good enough to 
regulate the displacement of the magnetic nanoparticles. 
The best results are achieved by seven numbers of coils 
with 2 in the central Halbach array. By increasing the surface 
of the coils from 5 cm to 20 cm, the flux density achieved 
was higher. However, after reaching the coil size of 20 cm, 
there was no further increase in the flux density distance 
or the distance of the force/weight values from the central 
coil. This could change the angle subtended (cos θ) by the 
magnetic coils with respect to neighboring other coils. The 
Jacobian matrix analysis also revealed similar results for 
dB/dx and dB/dy (Figure 9c). The ellipsoidal model and 
the back-to-back placement of coils did not enhance the 
results; and in fact, the force/wt. and the magnetic flux 
density parameters were lesser compared to the square 
models of the coils. The displacement of the particles was 
demonstrated in saline when the results were tested with 
increased drag forces. The movement of the particles 
was higher when the inertia of the particles was ignored. 
The displacement parameters were evident even when 
the magnetic nanoparticle size was reduced to 15 nm. 
Hence, looking at the results, it is possible to achieve good 
control on the particles by external application of magnetic 
field within a range of 10–15 cm, and the computational 
results can be seen in saline and possibly in the tissues 
also which needs to be evaluated further. Elaborate 
presentation of the robust data is not possible within the 
scope of this article. Hence, the details are further seen 
in the Quickfield reference website with a supplement to 
this article, which the readers of this study can go through.
Discussion
The study results show the electromagnetic 
behavior of the magnetic nanoparticles in the magnetic 
field. The purpose of the study was to increase the force 
density as well as the magnetic field gradient to maximum 
possible higher limits. The maximum distance was 11 cm 
distance where a force/weight ratio of about 300 at 11 cm 
length was achieved in the X-axis. This can be used for 
therapeutic purposes. The magnetic nanoparticles can 
be injected in the retrosternal space in a line; and the 
movement of the magnetic nanoparticles can be controlled 
with external magnetic field to the target arteries which 
could be left internal mammary artery (LIMA) adjacent 
to the left anterior descending artery (i.e., LIMA to LAD 
grafting). The neighboring arteries to the coronaries can 
also be utilized as a potential target. However, this needs 
to be evaluated in future experimental studies for further 
validation and observations. The motion of the magnetic 
nanoparticles was already demonstrated from the surface, 
and the motion of the magnetic nanoparticles was studied 
in detail including the Brownian motion of the surrounding 
fluid and dipole-dipole interaction of the particles among 
themselves has some effect on the trajectory, however, 
this change in the trajectory is minimal [15], [16].
Coronary artery bypass, chronic total 
occlusions, and peripheral vascular surgery
The conventional coronary artery bypass 
surgery and peripheral vascular surgery are routinely 
performed, and they are effective as a therapy. The 
1-year mortality rate in coronary artery bypass surgery 
is about 6.2%. The post-operative neurological 
complications are seen in about 1.4% [17], acute renal 
failure in 2%, and nosocomial infections are seen in 10% 
of patients [18], [19], [20], [21], [22]. Furthermore, the 
complication rates are more in frail individuals. These 
surgeries tend to have along waiting period also for various 
logistic reasons [23]. Hence, a simple novel therapy as a 
bypass technique would be potentially useful. Peripheral 
vascular surgeries are associated with a graft occlusion 
rate of 10%, post-operative infections, and hemorrhages 
of 5% each and a mortality rate of 3% [24], [25].
Chronic total occlusions have a success rate 
of about 60–70% and the revascularization benefits 
are still debatable [26]. A sizable number of patients 
with coronary artery disease, i.e., 5–10% are classified 
having refractory angina, and they do not have 
suitable therapy. In this large subgroup of patients the 
nanoparticles if they induce angiogenesis, it will be 
therapeutically very useful [27], [28].
Angiogenesis focus
Angiogenesis can happen when the endothelial 
cells and extracellular matrix crosstalk and sprouting 
happens with the effect of VEGF which is a powerful 
stimulus for angiogenesis. The cross-wiring is further 
stimulated by hypoxia and certain electrochemical 
stimuli [29], [30], [31], [32], [33]. However, angiogenesis 
is complicated due to very short half-life of pro-
angiogenic factors and its rapid clearance by the 
surrounding tissues [29]. The violet areas in the five-coil 
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simulation (Figures 20 and 21) with a distance of 15 cm 
between the coils also show high force values in the 
acceptable range of 15 cm. This potential benefit can 
be utilized, for example, by interposing a tissue/or an 
ischemic limb; and the magnetic nanoparticle coated 
with functional biomolecules can be injected in specific 
locations for therapeutic purposes to form collaterals. 
This can induce angiogenesis with VEGF conjugation 
or it can use for therapeutic occlusion. Furthermore, 
an internally placed magnet can absorb the magnetic 
nanoparticles on to the surface.
Figure 21: Particle acceleration in the violet areas (supplement file 22 
for force values in the violet areas)
Feasibility for percutaneous coronary 
artery bypass technique
Formation of collaterals between the coronary 
arteries and adjacent arteries such as the right and LIMA, 
as well as the epigastric arteries, is theoretically feasible 
by this technique. The idea is very promising; however, 
this needs to be evaluated by further studies in vitro 
and in vivo. As an extension of this principle, it can be 
used for collaterals in peripheral and cerebrovascular 
arteries also. In modern times, robotic cardiac surgery 
has been developed in advanced centers. However, 
despite advancements due to high working cost and 
the large learning curve, the technology is still in the 
developing stages only [34].
Coagulation focus
The nanoparticles conjugated with pro-
coagulation biomolecules and coagulation can be 
induced at the target locations. This can be used 
to control or modulate bleeding when required in 
specific focussed areas for hemostasis. Conversely, 
anticoagulation can be induced in the necessary 
locations by appropriate conjugations.
Renal interventions
The glomerulus filters the magnetic nanoparticle 
of sizes less than 10 nm, and thereby, their applications 
could be widened for potential renal therapies. This 
could be in the scenario of immune complex diseases 
or toxic clearances. However, this is preliminary and 
needs to be extensively studied.
Toxicity of magnetic nanoparticles
Magnetic nanoparticles are toxic in 
higher doses [35]. The toxic dose is in the range of 
150–300 mg/kg. At this higher dose, it can cause 
myocardial necrosis and oxidative damages. Liver and 
spleen were the significant organs affected at a dosage 
of 1.7 g Fe/kg.
Velocity and controlled displacement 
kinetics
The particles had maximal velocity kinetics of 
32 cm/s when the particles were placed in air subjected 
to an external magnetic field. The venous blood has a 
velocity of 10–15 cm/s [36]. Hence, when the magnets 
are placed internally, a good acceleration toward the 
coil can be achieved. In tissues, the particles are 
encountered with resistance due to the intermolecular 
resistance forces which prevent the displacement 
of the particles. The displacement of the particles 
happens even when the resistance forces or the drag 
forces were kept 3–5 times that of the saline, as shown 
in Figure 16e and f. The controlled displacement is 
enough to prove the control of the particles at least in 
one axis by external magnetic forces.
Heat generation
High magnetic energy generation would be 
associated with heat generation, and this needs to be 
quantified. Since the magnetic field source analyzed in 
this study is placed externally, the heat generation can 
be controlled by various cooling methods which can be 
placed outside.
Limitations and future perspectives
The study was performed in a two-dimensional 
simulation method. 3D computations would give more 
information as well as the possible additions of more 
number of coils in the proposed models. Furthermore, 
the effect of motion of the coils could not be estimated 
and these are the limitations. To a certain extent in 
this study, motion studies were simulated using A/C 
current instead of D/C. However, in the results, there 
were no apparent changes in the magnetic intensity 
of force/weight parameters by changing to A/C. The 
drag force acting on the particles in motion needs to 
be quantified by experiments. However, the velocity 
kinetics shows excellent values and this is faster 
than the venous flow. Hence, the particles can be 
 Arokiaraj and Liubimtcev: Magnetic Nanoparticles Evaluation in High Magnetic Fields
Open Access Maced J Med Sci. 2020 Feb 15; 8(A):24-36. 35
trapped or eliminated from the venous system. More 
details of the kinetics need to be estimated by other 
studies and experiments. The particle release and 
control dynamics of the biomolecules at the tissue 
level need to be determined [37]. Furthermore, the 
horseshoe model needs to be evaluated at a higher 
magnetic force level so that controlling the particles 
is even easier [38]. Perfluorocarbon nanobubbles 
have been shown to have efficacy in reducing 
hypoxic cardiomyocyte injury [39]. Furthermore, the 
perfluorocarbon nanobubbles could be conjugated 
with magnetic nanoparticles [40]. Hence, this 
technique after conjugation can be evaluated by 
bench studies to identify its potential in myocardial 
salvage in acute coronary syndromes.
Conclusion
There is potential for a novel method of 
controlling multifunctional magnetic nanoparticles using 
high magnetic fields. Further studies are required to 
evaluate the motion characteristics of these particles 
in vivo and in vitro.
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